IFI-M · UAS Tri-Axis Balanced Series

Specimen SS-F-M3-02320 // MULTI-AXIS · IFI-M

UAS Tri-Axis Balanced Series IV-NP

Solanum lycopersicum

Tomato

Tier IVUAS Tri-Axis Balanced Series

Target Trait

2.13×

fold-change

Umami+Astringency+Sweet balanced tri-axis fold-change

Technical Specifications

SKU

SS-F-M3-02320

Genomic Edits

10

GC Content

44.2%

Construct Length

5,728 bp

Promoter System

Lipid nanoparticle / Ubiquitin

Expression System

Nanoparticle delivery

Host Strain

LNP-mediated

Receptor Target

mGluR1 + Polyphenol-astringency axis + TAS1R2/TAS1R3

IFI Score

213

Pathway Edits

  • mGluR1 pathway primary gene cluster for umami (IFI-U) tri-axis component
  • Polyphenol-astringency axis pathway primary gene cluster for astringency (IFI-A) tri-axis component
  • TAS1R2/TAS1R3 pathway primary gene cluster for sweet (IFI-S) tri-axis component
  • Tri-axis metabolic flux partitioning hub for concurrent UAS pathway operation
  • Cross-pathway regulatory circuit for balanced UAS triple-axis expression
  • Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: mGluR1, Polyphenol-astringency axis, and TAS1R2/TAS1R3 pathways simultaneously engineeredBalanced tri-axis expression strategy (UAS) with cross-pathway flux managementLNP-mediated delivery of triple-axis mRNA panel for transient expression profiling

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier IV UAS triple-axis construct for advanced multi-modal sensory architecture combining umami, astringency, and sweet axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$4249 · Tier IV License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-MAll Modalities